Press Releases

Webcast
T2 Biosystems Inc. at the Cantor Fitzgerald Global Healthcare Conference (Live)
Monday, September 25, 2017 10:55 am EDT
Date Title
12/07/18
Summary ToggleT2 Biosystems Reports Granting of Inducement Awards Printer Friendly Version LEXINGTON, Mass. , Dec. 07, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on December 4, 2018 it issued inducement awards to six new
11/08/18
Summary ToggleT2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum Printer Friendly Version LEXINGTON, Mass. , Nov. 08, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that John McDonough , president and chief executive officer, is
11/07/18
Summary ToggleT2 Biosystems Reports Granting of Inducement Awards Printer Friendly Version LEXINGTON, Mass. , Nov. 07, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on November 1, 2018 it issued inducement awards to six new
11/01/18
Summary ToggleT2 Biosystems Reports Third Quarter 2018 Financial Results and Provides Corporate Update Printer Friendly Version Quarterly Product Revenue Up 71% Year-Over-Year Reiterates 2018 Financial Guidance LEXINGTON, Mass. , Nov. 01, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in
10/18/18
Summary ToggleT2 Biosystems Announces 2018 Third Quarter Financial and Operational Results Release and Conference Call Date Printer Friendly Version LEXINGTON, Mass. , Oct. 18, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (Nasdaq: TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, today announced that it will release its 2018 third quarter financial and
10/05/18
Summary ToggleT2 Biosystems Reports Granting of Inducement Awards Printer Friendly Version LEXINGTON, Mass. , Oct. 05, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on October 2, 2018 it issued inducement awards to four new
10/03/18
Summary ToggleT2 Biosystems Announces Customer Presentations at October Conferences Printer Friendly Version IDWeek and World Antimicrobial Resistance Congress to feature presentations on T2Bacteria and T2Candida Panels LEXINGTON, Mass. , Oct. 03, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for
09/26/18
Summary ToggleNew Data Suggests T2 Biosystems’ T2Lyme™ Panel is More Accurate than Other Diagnostics for Identifying Borrelia Infections for Patients Suspected of Having Early Lyme Disease Printer Friendly Version Data presented at International Conference on Lyme Borreliosis and Other Tick-Borne Diseases LEXINGTON, Mass. , Sept. 26, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs
09/10/18
Summary ToggleT2 Biosystems to Participate in Two Upcoming Investor Conferences Printer Friendly Version

LEXINGTON, Mass. , Sept. 10, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that John McDonough , president and chief executive

09/07/18
Summary ToggleT2 Biosystems Reports Granting of Inducement Awards Printer Friendly Version LEXINGTON, Mass. , Sept. 07, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on September 5, 2018 it issued inducement